Top Pulmonary Hypertension Research Leaders (KOLs) 2021-2026

Top research leaders (by recent publication volume)

#	Researcher	Affiliation	Papers
1	Humbert Marc	Université Paris-Saclay	21
2	Gomberg-Maitland Mardi	George Washington University School of Medicine and Health	16
3	Souza Rogerio	Hospital das Clínicas da Faculdade de Medicina da Universi	13
4	de Oliveira Pena Janethe	Merck & Co.	12
5	Montani David	Université Paris-Saclay	8
6	Park Da-Hee	Hannover Medical School	7
7	Savale Laurent	Université Paris-Saclay	7
8	Kopeć Grzegorz	Jagiellonian University Medical College	7
9	Meyer Gisela	Irmandade da Santa Casa de Misericórdia de Porto Alegre	7
10	Manimaran Solaiappan	Merck & Co.	7
11	Ghofrani H Ardeschir	Justus-Liebig University Giessen	6
12	Miller Barry	Merck & Co.	6
13	Rosenkranz Stephan	University Hospital Cologne	6
14	Sahay Sandeep	Houston Methodist Hospital	6
15	Boucly Athénaïs	Université Paris-Saclay	5
16	Sitbon Olivier	Université Paris-Saclay	5
17	Madonna Rosalinda	University of Pisa	5
18	McLaughlin Vallerie	University of Michigan Health System	5

Ranked by recent publication volume; names not yet disambiguated and not citation-weighted. The full brief adds ORCID disambiguation, citation weighting, and clinical-trial investigator data.

Leading institutions

Université Paris-Saclay (20), Imperial College London (13), Merck & Co. (13), University of Michigan (11), Brigham and Women's Hospital (11), George Washington University School of Medicine and Health (10), Hannover Medical School (10), University of Colorado (8), Lahey Hospital and Medical Center (6), Justus-Liebig-University Giessen (6)

Active subtopics

Pulmonary Arterial Hypertension (99), Recombinant Fusion Proteins (64), Hypertension, Pulmonary (61), Treatment Outcome (35), Antihypertensive Agents (29), Signal Transduction (17), Familial Primary Pulmonary Hypertension (17), Pulmonary Artery (16)

Top journals

Pulmonary circulation (14), The European respiratory journal (14), American journal of respiratory and critical care medicine (8), The New England journal of medicine (7), The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation (6), Chest (6)

Representative recent papers

Transforming Pulmonary Arterial Hypertension: Key Milestones and Future Perspectives. (2026) · PMID 42441757

RKER-012, a modified ActRIIB-Fc ligand trap with BMP sparing properties, attenuates pathological features of experimental pulmonar (2026) · PMID 42422175

What sotatercept can teach us about the right ventricle in pulmonary arterial hypertension. (2026) · PMID 42364793

Off-Label Sotatercept Use in Pediatric Pulmonary Arterial Hypertension: A Single-Center Retrospective Hemodynamic Study. (2026) · PMID 42360428

Sotatercept as a Therapeutic Option for Systemic Sclerosis-Associated Pulmonary Arterial Hypertension With Features of PVOD/PCH. (2026) · PMID 42358521

Want the full cited brief?

A full Pulmonary Hypertension brief adds citation weighting, name disambiguation, clinical-trial investigators, and a cited PDF, scoped to your exact molecule, competitor set, or region.

Try the live tool Contact us